Allworth Financial’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Allworth Financial’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-40	Closed	-$455	–	3719
2023 Q4	$455	Hold	40	–	–	﹤0.01%	3153
2023 Q3	$162	Buy	+40	New	+$296	﹤0.01%	3256

Allworth Financial's HARP Position: Q1 2024 in Review

Allworth Financial sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 40 shares — an estimated $455 sold.

Allworth Financial first reported a position in HARP in Q3 2023 and held it in 2 quarters. The position peaked at $455 in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Allworth Financial reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Allworth Financial sold 40 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $455.
Allworth Financial first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Allworth Financial's Harpoon Therapeutics, Inc. Common Stock position peaked at $455 in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Allworth Financial's 13F filing for Q1 2024, filed 25 Apr 2024.